DNM1L and cancer: Multiple studies have demonstrated that enhanced fission or reduced fusion, high expression or enhanced activation of Drp1, and/or downregulation of MFN2 are linked to several cancer-related phenotypes [28, 29], indicating that cancer cells often exhibit fragmented mitochondria [30].